ArticleOncotarget2016

Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis.

Chien-Ju Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.